Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS

Neurology

Volumn 52, Issue 3, 1999, Pages 595-599

  Schrijver, H M ^a   Crusius, J B A ^a   Uitdehaag, B M J ^a,b   Garcia Gonzalez M A ^a   Kostense, P J ^a   Polman, C H ^a   Pena A S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; ALLELE; GENETICS; MIDDLE AGED;

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR;

ADULT; ALLELES; FEMALE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1;

EID: 0032588597     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.595     Document Type: Article

References (30)

1. Dyment DA, Sadovnick AD, Ebers GC. Genetics of multiple sclerosis. Hum Mol Genet 1997;6:1693-1698.
2. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-113.
3. Dinarello CA. Biology of interleukin 1. FASEB J 1988;2:108-115.
4. Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK. There is more than one interleukin 1. Immunol Today 1986;7:430-436.
5. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995;45(suppl 6):S16-S21.
6. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991;88:1445-1451.
7. Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB. The human IL-1 receptor antagonist gene (IL-1rn) maps to chromosome 2q14-21 in the region of the IL-1 and IL-1 loci. Genomics 1992;13:654-657.
8. Pociot F, Mølvig J, Wogensen L. A TaqI polymorphism in the human interleukin-1 (IL-1) gene correlates with IL-1 secretion in vitro. Eur J Clin Invest 1992;22:396-402.
9. Tarlow JK, Blakemore AIF, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-404.
10. Tarlow JK, Clay FE, Cork MJ, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994;103:387-390.
11. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106:637-642.
12. Bioque G, Bouma G, Crusius JBA, et al. Evidence for genetic heterogeneity in IBD. 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol 1996;8:105-110.
13. Heresbach D, Alizadeh M, Dabadie A, et al. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997;92:1164-1169.
14. Crusius JBA, Pena AS, van Oosten BW, et al. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995;346:979-980.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
16. Lublin FD, Reingold SC. Defining the course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
17. Bioque G, Crusius JBA, Koutroubakis I, et al. Allelic polymorphism in IL-1 and IL-1 receptor antagonist (IL-1RA) genes in inflammatory bowel disease. Clin Exp Immunol 1995;102: 379-383.
18. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 1995;45(suppl 6):S11-S15.
19. Huang WX, He B, Hillert J. An interleukin 1 receptor antagonist gene polymorphism is not associated with multiple sclerosis. J Neuroimmunol 1996;67:143-144.
20. Semana G, Yaouanq J, Alizadeh M, Clanet M, Edan G. Interleukin-1 receptor antagonist gene in multiple sclerosis. Lancet 1997;349:476.
21. De la Concha EG, Arroyo R, Crusius JBA, et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing-remitting multiple sclerosis. J Neuroimmunol 1997;80:172-178.
22. Wansen K, Pastinen T, Kuokkanen S, et al. Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCR beta, IGH, IFN-gamma and IL-1ra/IL-1 beta loci. J Neuroimmunol 1997;79:29-36.
23. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-310.
24. Voltz R, Hartmann M, Spuler S, et al. Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist. J Neurol Neurosurg Psychiatry 1997;62:200-201.
25. Nicoletti F, Patti F, DiMarco R, et al. Circulating serum levels of IL-1ra in patients with relapsing-remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine 1996;8:395-400.
26. Arend WP, Smith MF Jr, Janson RW, Joslin FG. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. J Immunol 1991;147:1530-1536.
27. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol 1995; 154:2434-2440.
28. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1 genes. Eur J Immunol 1998;28:2598-2602.
29. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1 production in vitro. Scand J Immunol 1998;47:195-198.
30. Filippi M, Horsfield MA, Morrissey SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994; 44:635-641.